DaVita Inc. (NYSE:DVA) Stock Position Reduced by Romano Brothers AND Company

Romano Brothers AND Company cut its stake in shares of DaVita Inc. (NYSE:DVA) by 0.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,625 shares of the company’s stock after selling 100 shares during the period. Romano Brothers AND Company’s holdings in DaVita were worth $1,637,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Resources Management Corp CT ADV grew its position in DaVita by 5,900.0% in the second quarter. Resources Management Corp CT ADV now owns 300 shares of the company’s stock worth $30,000 after acquiring an additional 295 shares in the last quarter. Parkside Financial Bank & Trust grew its position in DaVita by 88.6% in the first quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock worth $35,000 after acquiring an additional 147 shares in the last quarter. Harbor Investment Advisory LLC bought a new stake in DaVita in the third quarter worth approximately $34,000. Hanseatic Management Services Inc. bought a new stake in DaVita in the third quarter worth approximately $36,000. Finally, FinTrust Capital Advisors LLC grew its position in DaVita by 242.3% in the third quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock worth $67,000 after acquiring an additional 504 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on DVA shares. Barclays started coverage on shares of DaVita in a report on Wednesday, March 6th. They set an “equal weight” rating and a $133.00 price objective for the company. Truist Financial upped their price objective on shares of DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Tuesday, February 20th. TheStreet raised shares of DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. UBS Group upped their price objective on shares of DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. Finally, StockNews.com raised shares of DaVita from a “buy” rating to a “strong-buy” rating in a report on Monday, April 8th. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, DaVita currently has an average rating of “Moderate Buy” and an average price target of $118.50.

DaVita Stock Performance

NYSE:DVA traded down $0.98 during trading hours on Friday, hitting $130.42. 513,129 shares of the company traded hands, compared to its average volume of 694,723. The stock has a market capitalization of $11.44 billion, a price-to-earnings ratio of 17.62, a P/E/G ratio of 1.16 and a beta of 1.04. DaVita Inc. has a twelve month low of $71.51 and a twelve month high of $141.54. The firm has a 50-day moving average of $128.95 and a 200 day moving average of $107.96. The company has a current ratio of 1.19, a quick ratio of 1.13 and a debt-to-equity ratio of 6.65.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, beating the consensus estimate of $1.53 by $0.34. DaVita had a net margin of 5.70% and a return on equity of 64.42%. The firm had revenue of $3.15 billion during the quarter, compared to analysts’ expectations of $3.01 billion. During the same period in the prior year, the company earned $1.11 EPS. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. On average, analysts forecast that DaVita Inc. will post 9.23 EPS for the current year.

Insider Activity

In other news, CEO Javier Rodriguez sold 67,603 shares of the stock in a transaction on Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the completion of the transaction, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, COO Michael David Staffieri sold 29,488 shares of the stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $119.81, for a total transaction of $3,532,957.28. Following the completion of the sale, the chief operating officer now owns 37,687 shares in the company, valued at approximately $4,515,279.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Javier Rodriguez sold 67,603 shares of the stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares of the company’s stock, valued at approximately $61,629,578.67. The disclosure for this sale can be found here. In the last 90 days, insiders sold 134,540 shares of company stock worth $16,551,071. 1.40% of the stock is currently owned by corporate insiders.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.